Gallic Acid

Product Details

CAS No:149-91-7

MF:C7H6O5

Appearance:white or off-white crystalline powder

Specification:99.0%

UN number:-

Package:1/5/10/25kgs/drum

Supply Capacity:Tons

Product application:Gallic Acid, 3,4,5-Trihydroxybenzoic acid, CAS 149-91-7, Gallic acid powder, Food grade Gallic Acid, Industrial grade Gallic Acid, Pharmaceutical grade Gallic Acid, Gallic acid anhydrous, Gallic acid monohydrate, Gallic acid price, Gallic acid manufacturer, Antioxidant additives, Semiconductor cleaning chemicals, Intermediate for Trimethoprim, Gallic acid solubility, Gallic acid benefits, Gallic acid MSDS, High purity Gallic Acid 99%, Natural polyphenols, Chinese nutgall extract.

Synonyms:Gallic acid, 98% 250GR;Gallic acid, 98% 5GR;Gallic acid 0;3,4,5-Trihydroxybenzoic acid, anhydrous 99%;Gallic acid, 5-Carboxybenzene-1,2,3-triol;BETZ 0276;GALLIC ACID;GALLIC ACID-1-HYDRATE,Gallic Acid,"Gallic acid; 149-91-7; 3,4,5-Trihydroxybenzoic acid; Benzoic acid, 3,4,5-trihydroxy-; Gallic acid, tech.; Kyselina gallova; Pyrogallol-5-carboxylic acid; CHEBI:30778; NSC-20103; NSC-674319; DTXSID0020650; 632XD903SP; NSC20103; DTXCID60650; Acid, Gallic; Gallic Acid 1520; 3,4,5-hydroxybenzoic acid; 205-749-9; gallate; MFCD00002510; GALOP; GALLIC ACID ANHYDROUS; HSDB 2117; 3,4,5-Trihydroxybenzoate; CCRIS 5523; NSC 674319; AI3-16412; Kyselina 3,4,5-trihydroxybenzoova; 3,4,5-Trihydroxybenzoic acid, anhydrous; CHEMBL288114; 3,4,5-trihydroxy-Benzoic acid; NSC674319; NCGC00091125-01; Kyselina gallova [Czech]; CAS-149-91-7; Gallic acid [NF]; SR-05000001537; EINECS 205-749-9; NSC 20103; BRN 2050274; gallic-acid; UNII-632XD903SP; Kyselina 3,4,5-trihydroxybenzoova [Czech]; Gallic acid tech.; Gallic Acid, F; GDE; Deuterated gallic acid; Spectrum_000342; Gallic acid (Standard); SpecPlus_000307; 5-Trihydroxybenzoic acid; Spectrum2_000399; Spectrum3_000254; Spectrum4_001544; Spectrum5_000108; GALLIC ACID [MI]; bmse000389; 3,5-Trihydroxybenzoic acid; GALLIC ACID [HSDB]; WLN: QVR CQ DQ EQ; 3,4,5-trihydroxy-Benzoate; Oprea1_087792; SCHEMBL15012; 3,4,5-Trihydroxybenzoicacid; BSPBio_001668; KBioGR_002008; KBioSS_000822; SPECTRUM210369; 3-10-00-02070 (Beilstein Handbook Reference); 65271-60-5; BIDD:ER0374; DivK1c_006403; GALLIC ACID [WHO-DD]; SCHEMBL407763; SPBio_000617; 3,4,5-Trihydroxybenzoate, X; Benzoic acid,4,5-trihydroxy-; GTPL5549; orb1310208; HY-N0523R; KBio1_001347; KBio2_000822; KBio2_003390; KBio2_005958; KBio3_001168; CPD-183; DTXSID50420476; Gallic acid, puriss., 98.0%; MSK2307; 1,5-Cyclohexadiene-1-carboxylic acid, 5-hydroxy-3,4-dioxo-; HMS1923K07; HMS2091A07; HMS5083N19; HMS6019I06; Pharmakon1600-00210369; BCP18127; HY-N0523; NSC36997; ULA66092; Tox21_111089; Tox21_202515; BBL009937; BDBM50085536; CCG-38670; NSC-36997; NSC755825; s4603; SBB008781; STK298718; AKOS000119625; Tox21_111089_1; AC-1206; CS-8191; FG11942; NSC-755825; PS-8710; SDCCGMLS-0066503.P001; 3,4,5-Trihydroxybenzoic acid anhydrous; NCGC00091125-02; NCGC00091125-03; NCGC00091125-04; NCGC00091125-05; NCGC00091125-07; NCGC00091125-13; NCGC00091125-14; NCGC00260064-01; DA-33612; ST083487; SY038078; SBI-0052184.P002; Gallic acid, 97.5-102.5% (titration); G0011; NS00013682; EN300-21542; C01424; D85056; 3,4,5-trihydroxybenzoic acid (ACD/Name 4.0); AB00052697_03; Q375837; SR-05000001537-1; SR-05000001537-2; SR-05000001537-3; BRD-K77345217-001-01-9; BRD-K77345217-001-05-0; F1908-0156; Gallic acid, certified reference material, TraceCERT(R); Z104501122; 78563C7D-0E2D-4766-A8EA-670A03C78FCF; InChI=1/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,8-10H,(H,11,12; 137657-43-3",170.120,C7H6O5,